CGON CG Oncology, Inc. - Common stock
$65,31
Fiyat · May 20, 2026
Temel veriler itibarıyla May 8, 2026
52 Haftlık Aralık
$24–$76
80% of range
Analist Derecelendirmesi
BUY
21 analysts
Fiyat Hedefi
$90
+38% upside
P/E (TTM)
-20.0
ROE
-22.6%
Net Kâr Marjı
-3985.0%
CGON Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$65.31
Piyasa Değeri
$3.35B
P/E (TTM)
-20.0
EPS (TTM)
$-2.08
Gelir (TTM)
$4M
Temettü Verimi
—
ROE
-22.6%
D/E Borç/Özsermaye
0.0
52 Haftlık Aralık
$24 – $76
CGON Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$4M
2023-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.08
2023-12-31
→
2025-12-31
Serbest Nakit Akışı
$-132M
2024-12-31
→
2025-12-31
Marjlar
-3985.0%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
CGON
Akran Ortalaması
P/E (TTM)
-20.0
14.7
P/S (TTM) (F/S (TTM))
829.3
41.0
P/B (F/D)
4.5
11.4
EV / EBITDA
-13.8
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-25.3
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
CGON
Akran Ortalaması
Operating Margin (Faaliyet Kâr Marjı)
-4722.1%
—
Net Profit Margin (Net Kâr Marjı)
-3985.0%
-110.3%
ROA
-20.8%
-31.3%
ROE
-22.6%
-60.8%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
CGON
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.0
18.4
Current Ratio (Cari Oran)
24.6
9.0
Quick Ratio (Cari Oran)
24.1
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
CGON
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
254.7%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
CGON
Akran Ortalaması
CGON Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
21 analist
- Güçlü Al 5 23,8%
- Al 15 71,4%
- Tut 1 4,8%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
14 analist · 2026-05-17
Medyan
$88.50
← Tüm hedeflerin altında
$65.31
Düşük
$80.00
Yüksek
$108.00
Medyan hedef
$88.50
+35,5%
Ortalama hedef
$90.29
+38,2%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-0.03%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.71 | $-0.59 | -0.12% |
| 31 Aralık 2025 | $-0.53 | $-0.63 | 0.10% |
| 30 Eylül 2025 | $-0.57 | $-0.57 | 0.00% |
| 30 Haziran 2025 | $-0.54 | $-0.47 | -0.07% |
| 31 Mart 2025 | $-0.45 | $-0.41 | -0.04% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | — |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | — |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | — |
| SRRK | $4.78B | -13.4 | — | — | -157.9% | — |
| COGT | $5.72B | -16.4 | — | — | -83.1% | — |
| LEGN | — | — | — | — | — | — |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $4M | $1M | $204.0K | |
| R&D Expense | $117M | $82M | $46M | |
| SG&A Expense | $74M | $34M | $10M | |
| Operating Expenses | · | $116M | $56M | |
| Operating Income | $-191M | $-115M | $-55M | |
| Interest Income | $30M | $27M | $7M | |
| Other Non-op | $-152.0K | $3.0K | $-62.0K | |
| Income Tax | $-270.0K | $1.0K | $1.0K | |
| Net Income | $-161M | $-88M | $-49M | |
| EPS (Basic) | $-2.08 | $-1.41 | $-15.65 | |
| EPS (Diluted) | $-2.08 | $-1.41 | $-15.65 | |
| Shares (Basic) | 77,303,440 | 62,496,725 | 4,330,933 | |
| Shares (Diluted) | 77,303,440 | 62,496,725 | 4,330,933 | |
| EBITDA | $-189M | $-115M | · |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $32M | $257M | $8M | |
| Short-term Investments | $710M | $485M | $179M | |
| Receivables | $688.0K | $0 | · | |
| Inventory | $2M | $0 | · | |
| Prepaid Expense | $15M | $12M | $6M | |
| Current Assets | $759M | $754M | $194M | |
| PP&E (Net) | $16M | $272.0K | $69.0K | |
| PP&E (Gross) | $17M | $359.0K | · | |
| Accum. Depreciation | $1M | $87.0K | · | |
| Goodwill | $10M | $0 | · | |
| Intangibles | $575.0K | $0 | · | |
| Other Non-current Assets | $2M | $94.0K | $19.0K | |
| Total Assets | $792M | $755M | $199M | |
| Accounts Payable | $6M | $7M | $3M | |
| Current Liabilities | $31M | $21M | $14M | |
| Capital Leases | $3M | $52.0K | $244.0K | |
| Other Non-current Liabilities | $2M | $0 | · | |
| Total Liabilities | $39M | $21M | $15M | |
| Total Debt | $3M | · | · | |
| Common Stock | $8.0K | $8.0K | · | |
| Paid-in Capital | $1.13B | $951M | $7M | |
| Retained Earnings | $-379M | $-218M | $-130M | |
| Stockholders' Equity | $753M | $733M | $-123M | |
| Liabilities + Equity | $792M | $755M | $199M | |
| Shares Outstanding | 80,689,128 | 76,154,783 | 5,222,283 |
Nakit Akışı 13
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $1M | $32.0K | $17.0K | |
| Stock-based Comp | $27M | $11M | $2M | |
| Deferred Tax | $-278.0K | · | · | |
| Other Non-cash | $806.0K | $-2M | · | |
| Operating Cash Flow | $-132M | $-79M | $-46M | |
| CapEx | $134.0K | $234.0K | · | |
| Investing Cash Flow | $-246M | $-301M | $-121M | |
| Stock Issued | $147M | $223M | · | |
| Net Stock Activity | $147M | $223M | · | |
| Financing Cash Flow | $154M | $628M | $87M | |
| Net Change in Cash | $-225M | $249M | $-80M | |
| Taxes Paid | $16.0K | · | · | |
| Free Cash Flow | $-132M | $-79M | · |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -4722.1% | -10067.2% | · | |
| Net Margin | -3985.0% | -7729.5% | · | |
| EBITDA Margin | -4686.4% | -10064.4% | · | |
| ROA | -20.8% | -18.4% | · | |
| ROE | -22.6% | -13.9% | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 24.6 | 35.3 | · | |
| Quick Ratio | 24.1 | 34.7 | · | |
| Debt / Equity | 0.0 | · | · | |
| LT Debt / Equity | 0.0 | · | · |
Verimlilik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 11.7 | · | · |
Büyüme Oranları 1
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 254.7% | 458.3% | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $4M | $1M | $204.0K | |
| Net Income TTM | $-161M | $-88M | $-49M | |
| Market Cap | $3.35B | $2.18B | · | |
| Enterprise Value | $2.61B | · | · | |
| P/E | -20.0 | -20.3 | · | |
| P/S | 829.3 | 1917.6 | · | |
| P/B | 4.5 | 3.0 | · | |
| P / Tangible Book | 4.5 | 3.0 | · | |
| P / Cash Flow | -25.3 | -27.7 | · | |
| P / FCF | -25.3 | -27.7 | · | |
| EV / EBITDA | -13.8 | · | · | |
| EV / FCF | -19.7 | · | · | |
| EV / Revenue | 646.3 | · | · | |
| Earnings Yield | -5.0% | -4.9% | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $2M | $2M | $0 | $52.0K | $456.0K | $43.0K | $111.0K | $529.0K | $1.0K | $9.0K | $0 | $194.0K | |
| R&D Expense | $44M | $30M | $28M | $31M | $27M | $27M | $20M | $18M | $17M | $16M | $12M | $10M | $8M | |
| SG&A Expense | $21M | $18M | $23M | $17M | $15M | $12M | $9M | $7M | $6M | $3M | $2M | $2M | $2M | |
| Operating Expenses | · | · | · | $49M | $42M | · | $28M | $26M | $23M | · | $14M | $12M | $10M | |
| Operating Income | $-66M | $-49M | $-51M | $-49M | $-42M | $-38M | $-28M | $-26M | $-22M | $-19M | $-14M | $-12M | $-10M | |
| Interest Income | $6M | $7M | $7M | $7M | $8M | $6M | $8M | $7M | $6M | $3M | $2M | $771.0K | $1M | |
| Other Non-op | $-101.0K | $-53.0K | $-100.0K | $-4.0K | $5.0K | $6.0K | $-2.0K | $8.0K | $-9.0K | $-4.0K | $-8.0K | $-58.0K | $8.0K | |
| Net Income | $-60M | $-41M | $-44M | $-41M | $-34M | $-32M | $-20M | $-19M | $-17M | $-17M | $-12M | $-12M | $-9M | |
| EPS (Basic) | $-0.71 | $-0.52 | $-0.57 | $-0.54 | $-0.45 | $-0.47 | $-0.30 | $-0.28 | $-0.36 | $-4.50 | $-4.00 | $-3.93 | $-3.22 | |
| EPS (Diluted) | $-0.71 | $-0.52 | $-0.57 | $-0.54 | $-0.45 | $-0.47 | $-0.30 | $-0.28 | $-0.36 | $-4.50 | $-4.00 | $-3.93 | $-3.22 | |
| Shares (Basic) | 84,518,512 | -151,840,736 | 76,729,726 | 76,226,829 | 76,187,621 | -118,361,230 | 67,143,744 | 66,649,443 | 47,064,768 | -7,826,090 | 4,383,131 | 3,918,509 | 3,855,383 | |
| Shares (Diluted) | 84,518,512 | -151,840,736 | 76,729,726 | 76,226,829 | 76,187,621 | -118,361,230 | 67,143,744 | 66,649,443 | 47,064,768 | -7,826,090 | 4,383,131 | 3,918,509 | 3,855,383 | |
| EBITDA | $-66M | · | $-51M | $-49M | $-42M | · | $-28M | $-26M | $-22M | · | · | · | · |
Bilanço 25
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $32M | $45M | $15M | $41M | $257M | $43M | $25M | $77M | · | · | · | · | |
| Short-term Investments | $1.04B | $710M | $635M | $646M | $647M | $485M | $497M | $528M | $489M | · | · | · | · | |
| Receivables | $1M | $688.0K | $515.0K | · | · | $0 | · | · | · | · | · | · | · | |
| Inventory | $1M | $2M | $2M | · | · | $0 | · | · | · | · | · | · | · | |
| Prepaid Expense | $23M | $15M | $14M | $11M | $12M | $12M | $11M | $11M | $12M | · | · | · | · | |
| Current Assets | $1.10B | $759M | $696M | $673M | $701M | $754M | $552M | $564M | $579M | · | · | · | · | |
| PP&E (Net) | $15M | $16M | $15M | $253.0K | $264.0K | $272.0K | $63.0K | $84.0K | $77.0K | · | · | · | · | |
| PP&E (Gross) | $17M | $17M | $16M | · | · | $359.0K | · | · | · | · | · | · | · | |
| Accum. Depreciation | $2M | $1M | $623.0K | · | · | $87.0K | · | · | · | · | · | · | · | |
| Goodwill | $10M | $10M | $13M | · | · | $0 | · | · | · | · | · | · | · | |
| Intangibles | $560.0K | $575.0K | $2M | · | · | $0 | · | · | · | · | · | · | · | |
| Other Non-current Assets | $3M | $2M | $114.0K | $522.0K | $516.0K | $94.0K | $53.0K | $53.0K | $53.0K | · | · | · | · | |
| Total Assets | $1.14B | $792M | $730M | $701M | $728M | $755M | $552M | $564M | $579M | · | · | · | · | |
| Accounts Payable | $8M | $6M | $9M | $7M | $7M | $7M | $4M | $4M | $5M | · | · | · | · | |
| Current Liabilities | $35M | $31M | $31M | $30M | $23M | $21M | $16M | $12M | $10M | · | · | · | · | |
| Capital Leases | $4M | $3M | $3M | $706.0K | $781.0K | $52.0K | $71.0K | $118.0K | $184.0K | · | · | · | · | |
| Other Non-current Liabilities | $1M | $2M | $4M | · | · | $0 | · | · | · | · | · | · | · | |
| Total Liabilities | $43M | $39M | $42M | $31M | $23M | $21M | $16M | $12M | $10M | · | · | · | · | |
| Total Debt | $3M | · | $3M | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $9.0K | $8.0K | $8.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | · | · | · | · | |
| Paid-in Capital | $1.53B | $1.13B | $1.03B | $964M | $957M | $951M | $723M | $718M | $716M | · | · | · | · | |
| Retained Earnings | $-439M | $-379M | $-338M | $-294M | $-252M | $-218M | $-186M | $-166M | $-147M | · | · | · | · | |
| Stockholders' Equity | $1.09B | $753M | $688M | $670M | $705M | $733M | $537M | $552M | $569M | $-123M | · | · | · | |
| Liabilities + Equity | $1.14B | $792M | $730M | $701M | $728M | $755M | $552M | $564M | $579M | · | · | · | · | |
| Shares Outstanding | 88,007,761 | 80,689,128 | 78,277,452 | 76,231,859 | 76,221,289 | 76,154,783 | 67,537,858 | 66,659,852 | 66,636,252 | · | · | · | · |
Nakit Akışı 12
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $841.0K | $849.0K | $416.0K | $156.0K | $24.0K | $0 | $21.0K | $7.0K | $4.0K | $4.0K | $5.0K | $4.0K | $4.0K | |
| Stock-based Comp | $6M | $7M | $7M | $7M | $5M | $5M | $3M | $2M | $2M | $778.0K | $394.0K | $177.0K | $179.0K | |
| Other Non-cash | $-4M | · | · | · | $0 | · | · | · | $-11M | · | · | · | · | |
| Operating Cash Flow | $-57M | $-36M | $-39M | $-28M | $-29M | $-21M | $-16M | $-16M | $-26M | $-15M | $-12M | $-11M | $-8M | |
| CapEx | $304.0K | $7.0K | $97.0K | $14.0K | $16.0K | $209.0K | $-1.0K | $14.0K | $12.0K | · | · | · | · | |
| Investing Cash Flow | $-335M | $-76M | $15M | $1M | $-187M | $11M | $32M | $-36M | $-307M | $16M | $-161M | $103M | $-79M | |
| Stock Issued | $392M | $98M | · | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $392M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $393M | $99M | $54M | $-296.0K | $450.0K | $223M | $2M | $40.0K | $403M | $-3M | $106M | $-15M | $-765.0K | |
| Net Change in Cash | $1M | $-13M | $31M | $-27M | $-216M | $214M | $18M | $-52M | $69M | $-2M | $-68M | $77M | $-87M | |
| Taxes Paid | · | $0 | $5.0K | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-57M | · | · | · | $-29M | · | · | · | $-26M | · | · | · | · |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6130.1% | · | -3069.0% | · | -81161.5% | · | -65802.3% | -23291.0% | -4247.4% | · | · | · | · | |
| Net Margin | -5558.8% | · | -2629.5% | · | -66253.9% | · | -47453.5% | -17028.8% | -3200.8% | · | · | · | · | |
| EBITDA Margin | -6052.5% | · | -3069.0% | · | -81115.4% | · | -65802.3% | -23291.0% | -4246.7% | · | · | · | · | |
| ROA | -6.5% | · | -6.8% | -6.6% | -5.3% | · | -7.4% | -6.7% | -5.9% | · | · | · | · | |
| ROE | -6.7% | · | -7.2% | -6.8% | -5.4% | · | -7.6% | -6.8% | -5.9% | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.3 | · | 22.8 | 22.2 | 31.0 | · | 35.3 | 47.6 | 58.0 | · | · | · | · | |
| Quick Ratio | 30.6 | · | 22.3 | 21.8 | 30.4 | · | 34.6 | 46.6 | 56.7 | · | · | · | · | |
| Debt / Equity | 0.0 | · | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.0 | · | 0.0 | · | · | · | · | · | · | · | · | · | · |
Verimlilik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | 1.7 | · | 6.5 | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3M | · | $2M | $206.0K | $735.0K | · | $692.0K | $649.0K | $732.0K | · | · | · | · | |
| Net Income TTM | $-180M | · | $-140M | $-115M | $-91M | · | $-68M | $-59M | $-49M | · | · | · | · | |
| Market Cap | $5.96B | · | $3.15B | $1.98B | $1.87B | · | $2.55B | $2.10B | $2.93B | · | · | · | · | |
| Enterprise Value | $4.88B | · | $2.48B | · | · | · | · | · | · | · | · | · | · | |
| P/E | -29.8 | · | -21.7 | -16.6 | -17.6 | · | -7.6 | -3.7 | -3.8 | · | · | · | · | |
| P/S | 2126.5 | · | 1790.5 | 9621.5 | 2539.7 | · | 3682.4 | 3242.6 | 3996.4 | · | · | · | · | |
| P/B | 5.5 | · | 4.6 | 3.0 | 2.6 | · | 4.7 | 3.8 | 5.1 | · | · | · | · | |
| P / Tangible Book | 5.5 | · | 4.7 | 3.0 | 2.6 | · | 4.7 | 3.8 | 5.1 | · | · | · | · | |
| P / Cash Flow | -104.6 | · | · | · | -63.8 | · | · | · | -112.5 | · | · | · | · | |
| P / FCF | -104.0 | · | · | · | -63.7 | · | · | · | -112.4 | · | · | · | · | |
| EV / EBITDA | -74.5 | · | -48.4 | · | · | · | · | · | · | · | · | · | · | |
| EV / FCF | -85.3 | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1743.3 | · | 1405.9 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -3.4% | · | -4.6% | -6.0% | -5.7% | · | -13.1% | -27.2% | -26.2% | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Gelir | $4M | $1M | $204.0K |
| Faaliyet Kâr Marjı % | -4722.1% | -10067.2% | — |
| Net Gelir | $-161M | $-88M | $-49M |
| Seyreltilmiş Hisse Başı Kâr | $-2.08 | $-1.41 | $-15.65 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Borç / Öz Sermaye | 0.0 | — | — |
| Cari Oran | 24.6 | 35.3 | — |
| Cari Oran | 24.1 | 34.7 | — |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Serbest Nakit Akışı | $-132M | $-79M | — |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.